Segui
Jean Damascene Makuza
Jean Damascene Makuza
PhD student-School of Population and Public Health, University of British Columbia
Email verificata su bccdc.ca - Home page
Titolo
Citata da
Citata da
Anno
Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda
JD Makuza, S Nsanzimana, MA Muhimpundu, LE Pace, J Ntaganira, ...
Pan African Medical Journal 22 (1), 2015
1532015
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial
N Gupta, A Mbituyumuremyi, J Kabahizi, F Ntaganda, CM Muvunyi, ...
The lancet Gastroenterology & hepatology 4 (2), 119-126, 2019
882019
Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda
JD Makuza, JOT Rwema, CK Ntihabose, D Dushimiyimana, J Umutesi, ...
BMC infectious diseases 19, 1-10, 2019
632019
Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda
J Umutesi, B Simmons, JD Makuza, D Dushimiyimana, A Mbituyumuremyi, ...
BMC infectious diseases 17, 1-7, 2017
552017
Predictors of mortality in a paediatric intensive care unit in Kigali, Rwanda
R Nyirasafari, MH Corden, AC Karambizi, JC Kabayiza, JD Makuza, ...
Paediatrics and international child health 37 (2), 109-115, 2017
332017
Controlling hepatitis C in Rwanda: a framework for a national response
A Mbituyumuremyi, JI Van Nuil, J Umuhire, J Mugabo, M Mwumvaneza, ...
Bulletin of the World Health Organization 96 (1), 51, 2018
322018
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
JD Makuza, CY Liu, CK Ntihabose, D Dushimiyimana, S Umuraza, ...
BMC infectious diseases 19, 1-10, 2019
262019
Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population
J Umutesi, CY Liu, MJ Penkunas, JD Makuza, CK Ntihabose, S Umuraza, ...
BMJ open 9 (7), e029743, 2019
182019
Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment …
N Gupta, L Manirambona, F Shumbusho, J Kabihizi, A Murangwa, ...
The Lancet Gastroenterology & Hepatology 7 (6), 542-551, 2022
162022
Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial
F Kateera, F Shumbusho, L Manirambona, J Kabihizi, A Murangwa, ...
The Lancet Gastroenterology & Hepatology 7 (6), 533-541, 2022
102022
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach
I Kamali, DA Barnhart, F Nyirahabihirwe, J de la Paix Gakuru, M Uwase, ...
BMC infectious diseases 21, 1-9, 2021
102021
Hepatitis C virus in sub-Saharan Africa: a long road to elimination
R Shah, A Agyei-Nkansah, F Alikah, L Asamoah-Akuoko, YCO Bagou, ...
The Lancet Gastroenterology & Hepatology 6 (9), 693-694, 2021
102021
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study
I Kamali, DA Barnhart, JA Ndahimana, K Noor, J Mumporeze, ...
PloS one 16 (10), e0257917, 2021
92021
Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study
I Kamali, F Shumbusho, DA Barnhart, F Nyirahabihirwe, JP Gakuru, ...
BMC Infectious Diseases 22 (1), 272, 2022
72022
Screen, notify, see, and treat: initial results of cervical cancer screening and treatment in Rwanda
MA Muhimpundu, F Ngabo, F Sayinzoga, JP Balinda, J Rusine, ...
JCO Global Oncology 7, 632-638, 2021
72021
Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study
JD Makuza, MP Nisingizwe, JOT Rwema, D Dushimiyimana, ...
BMJ open 10 (7), e036711, 2020
72020
Direct-acting antiviral treatment in sub-Saharan Africa: A prospective trial of Ledipasvir/Sofosbuvir for chronic Hepatitis C infection in Rwanda (the SHARED study)
N Gupta, J Kabahizi, C Muvunyi, A Mbituyumuremyi, J Van Nuil, ...
Journal of Hepatology 68, S50, 2018
62018
The cascade of care for hepatitis C treatment in Rwanda: a retrospective cohort study of the 2017–2019 mass screening and treatment campaign
MP Nisingizwe, JD Makuza, NZ Janjua, N Bansback, B Hedt-Gauthier, ...
Viruses 15 (3), 661, 2023
52023
Cohort profile: the british columbia COVID-19 population mixing patterns survey (BC-Mix)
PA Adu, M Binka, B Mahmood, D Jeong, T Buller-Taylor, MJ Damascene, ...
BMJ open 12 (8), e056615, 2022
52022
Quantifying contact patterns: development and characteristics of the British Columbia COVID-19 population mixing patterns survey
P Adu, M Binka, B Mahmood, D Jeong, T Buller-Tylor, MJ Damascene, ...
International Journal of Infectious Diseases 116, S30-S31, 2022
52022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20